ID: ALA5278219

Max Phase: Preclinical

Molecular Formula: C18H21NO3

Molecular Weight: 299.37

Associated Items:

Representations

Canonical SMILES:  Cc1cc(=O)c(O)c(CN2CCC(c3ccccc3)CC2)o1

Standard InChI:  InChI=1S/C18H21NO3/c1-13-11-16(20)18(21)17(22-13)12-19-9-7-15(8-10-19)14-5-3-2-4-6-14/h2-6,11,15,21H,7-10,12H2,1H3

Standard InChI Key:  BJPRZFZZWYBYRG-UHFFFAOYSA-N

Associated Targets(non-human)

Mycolicibacterium smegmatis 8003 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 299.37Molecular Weight (Monoisotopic): 299.1521AlogP: 3.03#Rotatable Bonds: 3
Polar Surface Area: 53.68Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.45CX Basic pKa: 7.31CX LogP: 2.68CX LogD: 2.40
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.95Np Likeness Score: -0.19

References

1. He M, Fan M, Peng Z, Wang G..  (2021)  An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery.,  221  [PMID:34023737] [10.1016/j.ejmech.2021.113546]

Source